| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016095 | HBV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS10027270 | HBV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS30036612 | HIV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS30036613 | HIV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS20018652 | HPV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS20051864 | HPV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS20018653 | HPV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS20018654 | HPV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS20018655 | HPV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
| TVIS20017631 | HPV | ENSG00000257365.8 | protein_coding | FNTB | No | No | 2342 | P49356 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FNTB |
|---|---|
| DrugBank ID | DB07780 |
| Drug Name | Farnesyl diphosphate |
| Target ID | BE0002372 |
| UniProt ID | P49356 |
| Regulation Type | |
| PubMed IDs | 10592235 |
| Citations | Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Experimental |
| Direct Classification | Sesquiterpenoids |
| SMILES | CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O |
| Pathways | Cerivastatin Action Pathway; Desmosterolosis; Pamidronate Action Pathway; Ibandronate Action Pathway; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Hyper-IgD Syndrome; Hereditary Coproporphyria (HCP); Porphyria Variegata (PV); Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hypercholesterolemia; Acute Intermittent Porphyria; Risedronate Action Pathway; Mevalonic Aciduria; Porphyrin Metabolism; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; CHILD Syndrome; Congenital Erythropoietic Porphyria (CEP) or Gunther Disease; Cholesteryl Ester Storage Disease; Lovastatin Action Pathway; Wolman Disease; Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL69330 |
